D.A. Davidson & Co.

SEC CIK: 0001080107
Latest filing: Jul 24, 2026

SEC filings (opens in a new tab)

IBRX holding history

ImmunityBio, Inc. in every 13F filed by D.A. Davidson & Co., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

IBRX overview All 13F holders of IBRX Full Q2 2026 holdings

Shares (Q2 2026): 538,924
Value: $4.72M
% of portfolio: <0.1%
Quarters held: 2; Since Q1 2026

Holdings of IBRX by D.A. Davidson & Co., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	538,924	$4.72M	<0.1%	−19,285−3.5%	Reduced	Holders
Q1 2026	558,209	$4.28M	<0.1%	+558,209	New	Holders